We are live on ! Find out more
GMED icon

Globus Medical

184 hedge funds and large institutions have $1.46B invested in Globus Medical in 2014 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 57 increasing their positions, 61 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

100% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 21

29% more capital invested

Capital invested by funds: $1.13B → $1.46B (+$324M)

11% more funds holding

Funds holding: 166184 (+18)

5.05% more ownership

Funds ownership: 82.04%87.09% (+5.1%)

7% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 61

76% less call options, than puts

Call options by funds: $859K | Put options by funds: $3.57M

Holders
184
Holders Change
+18
Holders Change %
+10.84%
% of All Funds
4.91%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
42
Increased
57
Reduced
61
Closed
21
Calls
$859K
Puts
$3.57M
Net Calls
-$2.71M
Net Calls Change
-$2.57M
Name Holding Trade Value Shares
Change
Change in
Stake
LA
126
Lucus Advisors
New York
$476K +$443K +20,007 New
TAM
127
Tocqueville Asset Management
New York
$475K +$111K +5,000 +33%
EBIM
128
Eagle Boston Investment Management
Massachusetts
$473K +$441K +19,907 New
PNC Financial Services Group
129
PNC Financial Services Group
Pennsylvania
$462K +$124K +5,583 +40%
Fifth Third Bancorp
130
Fifth Third Bancorp
Ohio
$455K +$73.6K +3,324 +21%
Citigroup
131
Citigroup
New York
$448K +$335K +15,120 +406%
HI
132
HBK Investments
Texas
$398K -$1.81M -81,937 -83%
QI
133
Quotient Investors
New York
$383K
FA
134
FDx Advisors
Illinois
$370K +$344K +15,547 New
DekaBank Deutsche Girozentrale
135
DekaBank Deutsche Girozentrale
Germany
$352K +$323K +14,600 New
NCCM
136
Nine Chapters Capital Management
New Jersey
$342K +$319K +14,400 New
Goldman Sachs
137
Goldman Sachs
New York
$341K -$181K -8,173 -36%
ProShare Advisors
138
ProShare Advisors
Maryland
$336K -$266K -12,007 -46%
SJIM
139
St. Johns Investment Management
Florida
$329K
TI
140
Trexquant Investment
Connecticut
$322K +$301K +13,585 New
MCM
141
Manchester Capital Management
Vermont
$313K +$291K +13,165 New
DT
142
Diversified Trust
Tennessee
$311K +$290K +13,100 New
RG
143
Renaissance Group
Kentucky
$301K +$42K +1,896 +18%
BMCMI
144
Bryn Mawr Capital Management Inc
Pennsylvania
$297K +$277K +12,502 New
Principal Financial Group
145
Principal Financial Group
Iowa
$289K -$33.9K -1,529 -11%
CSS
146
Cubist Systematic Strategies
Connecticut
$267K +$112K +5,072 +82%
SCM
147
Stevens Capital Management
Pennsylvania
$257K +$240K +10,827 New
State Board of Administration of Florida Retirement System
148
State Board of Administration of Florida Retirement System
Florida
$254K
CL
149
Croft-Leominster
Maryland
$252K
ARTA
150
A.R.T. Advisors
New York
$244K -$82.1K -3,706 -26%

GMED Hedge Fund Activity: Q4 2014 in Review

184 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2014, worth a combined $1.46B — up 29% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new GMED positions and 21 closed out — a net gain of 21 holders — while 57 added to existing stakes and 61 trimmed.

The largest buyer was Kalmar Investments, opening a new position worth an estimated $43M. The largest seller was Deerfield Management, exiting entirely with an estimated $25.1M sold.

  • 184 institutional investors held Globus Medical (GMED) as of Q4 2014, up from 166 in Q3 2014.
  • Funds reported $1.46B of Globus Medical stock for Q4 2014, up 29% quarter-over-quarter.
  • 42 funds opened new Globus Medical positions in Q4 2014 and 21 closed out, a net change of +21 holders.
  • The largest Globus Medical buyer in Q4 2014 was Kalmar Investments, an estimated $43M added.
  • The largest Globus Medical seller in Q4 2014 was Deerfield Management, an estimated $25.1M sold.

Based on aggregated 13F filings for Q4 2014.